CD8A and neoplasm: Additionally, CD8 TEMRA displayed the highest degree of TCR sharing with peripheral blood, a phenomenon almost exclusively observed in responders which persisted on treatment, potentially suggesting that CD8 TEMRA are targeting tumour-specific antigens.